Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxiaStephanie G. Craig, Manuel Salto‐Tellez, Philip Quirke et al.|British Journal of Cancer|2020Cited by 63
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancerMatthew Alderdice, Darragh G. McArt, Stephanie G. Craig et al.|NAR Genomics and Bioinformatics|2021Cited by 22
Colonic epithelial cathelicidin (<scp>LL</scp>‐37) expression intensity is associated with progression of colorectal cancer and presence of <scp>CD8</scp><sup>+</sup> T cell infiltrateRoss J Porter, Mairi H McLean, Graeme I. Murray et al.|The Journal of Pathology Clinical Research|2021Cited by 15
The Potential of Digital Image Analysis to Determine Tumor Cell Content in Biobanked Formalin-Fixed, Paraffin-Embedded Tissue SamplesChristine Greene, Jacqueline A. James, Edwina O’Doherty et al.|Biopreservation and Biobanking|2021Cited by 8
ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer NetworkVivek Kumar Singh, Perry Maxwell, Md. Mostafa Kamal Sarker et al.|Cancers|2022Cited by 6